IRVINE, CA, and HERSTAL, BELGIUM - 07:00 CEST, July 6, 2017 - MDxHealth SA (Euronext:MDXH.BR) today announced the commercial launch of its AssureMDx (TM) for Bladder Cancer test in the United States ...
Dublin, Jan. 29, 2025 (GLOBE NEWSWIRE) -- The "Bladder Cancer Diagnostics Market by Test Type, by Stages, by Cancer Type, by End User, and By Region" report has been added to ResearchAndMarkets.com's ...
A faster, cheaper and more reliable test to detect bladder cancer has been developed, US scientists have said. The test, which provides results within an hour, checks for a protein in urine which ...
Clinical study launched in June 2022 with patient recruitment in Alberta with plans to expand to further sites across North America. The aim of the study is to validate a novel and minimally invasive ...
Patients with muscle-invasive bladder cancer who test positive for circulating tumor (ct)DNA after surgery to remove the cancer benefit from immunotherapy with atezolizumab compared to placebo whereas ...
Under the commercial agreement, A. Menarini Diagnostics will assume exclusive marketing of the non-invasive Bladder EpiCheck ® test in Europe in the months ahead, providing patients and clinicians ...
The deal gives clinicians in PathNet's national lab network access to Valar's AI-powered Vesta diagnostic portfolio for non-muscle invasive bladder cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback